By: Claire Logan

DEPDC5 Gene Mutation and Epilepsy

What is the DEPDC5 Gene?

The DEPDC5 gene provides instructions for making a protein that helps control how brain cells grow, develop, and communicate with one another. It is part of a system that acts like a regulator, helping make sure cells do not grow or become overactive when they should not. This system is especially important during brain development and continues to help brain cells function properly throughout life.

When there is a change, or variant, in the DEPDC5 gene, this regulating system does not work as it should. As a result, brain cells can become more excitable, making seizures more likely to occur. In some people, changes in DEPDC5 can also affect how parts of the brain develop before birth. DEPDC5-related conditions are usually inherited in an autosomal dominant pattern, meaning that a person only needs one altered copy of the gene to have an increased chance of developing the condition. However, not everyone who inherits a DEPDC5 variant develops epilepsy, and symptoms can vary greatly even among members of the same family.

DEPDC5-Related Epilepsy

DEPDC5 is one of the most common genes linked to inherited focal epilepsy, a type of epilepsy in which seizures begin in one area of the brain. Seizures can start at almost any age but often begin during childhood or adolescence. The exact symptoms depend on which part of the brain is affected. Some people remain aware during their seizures, while others may lose awareness or have seizures that spread to involve the whole brain.

The severity of DEPDC5-related epilepsy varies widely. Some individuals have only a few seizures that are well controlled with medication, while others have seizures that continue despite treatment. Some people have changes in brain development, such as focal cortical dysplasia, which means that a small area of the brain did not develop typically before birth. This type of brain difference can increase the risk of seizures. However, many people with DEPDC5-related epilepsy have normal brain scans and no obvious structural changes.

Most individuals with DEPDC5-related epilepsy have typical learning and development. However, some people, particularly those with more severe epilepsy or brain abnormalities, may experience developmental delays, learning difficulties, or other neurodevelopmental differences. The symptoms and severity can differ considerably from one person to another, even within the same family

Research and Treatment

There is currently no cure for DEPDC5-related epilepsy. Treatment focuses on reducing seizures and helping each person achieve the best possible quality of life. Anti-seizure medications are the most common treatment and are effective for many individuals. For people whose seizures do not respond well to medication, epilepsy surgery may be an option if the seizures come from a specific area of the brain that can be safely removed.

Researchers continue to study how changes in the DEPDC5 gene lead to epilepsy and are exploring new treatments that target the underlying biological pathways involved in the condition. One area of research is investigating medications that may help restore the normal balance of brain cell activity. Although these treatments are still being studied, they may offer new options in the future.

Families affected by DEPDC5-related epilepsy are often supported by a team of healthcare professionals, which may include neurologists, genetic counselors, therapists, and other specialists. Genetic testing can help confirm a diagnosis, guide treatment decisions, and provide information about the chance of the condition occurring in other family members.

Resources

Baldassari, S., Picard, F., Verbeek, N. E., van Kempen, M., Brilstra, E. H., Lesca, G., Conti, V., Guerrini, R., Bisulli, F., Licchetta, L., Pippucci, T., Tinuper, P., Hirsch, E., de Saint Martin, A., Chelly, J., Rudolf, G., Chipaux, M., Ferrand-Sorbets, S., Dorfmüller, G., Sisodiya, S., … Baulac, S. (2019). The landscape of epilepsy-related GATOR1 variants. Genetics in medicine : official journal of the American College of Medical Genetics, 21(2), 398–408. https://doi.org/10.1038/s41436-018-0060-2

Baulac, S., Ishida, S., Marsan, E., Miquel, C., Biraben, A., Nguyen, D. K., Nordli, D., Cossette, P., Nguyen, S., Lambrecq, V., Vlaicu, M., Daniau, M., Bielle, F., Andermann, E., Andermann, F., Leguern, E., Chassoux, F., & Picard, F. (2015). Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations. Annals of neurology, 77(4), 675–683. https://doi.org/10.1002/ana.24368  

Child Neurology Foundation. (n.d.). DEPDC5-related epilepsies. https://www.childneurologyfoundation.org/disorder/depdc5-related-epilepsies/

Dibbens, L. M., de Vries, B., Donatello, S., Heron, S. E., Hodgson, B. L., Chintawar, S., Crompton, D. E., Hughes, J. N., Bellows, S. T., Klein, K. M., Callenbach, P. M., Corbett, M. A., Gardner, A. E., Kivity, S., Iona, X., Regan, B. M., Weller, C. M., Crimmins, D., O’Brien, T. J., Guerrero-López, R., … Scheffer, I. E. (2013). Mutations in DEPDC5 cause familial focal epilepsy with variable foci. Nature genetics, 45(5), 546–551. https://doi.org/10.1038/ng.2599  

Samanta D. (2022). DEPDC5-related epilepsy: A comprehensive review. Epilepsy & behavior : E&B, 130, 108678. https://doi.org/10.1016/j.yebeh.2022.108678 Scerri T, Hildebrand MS, Kinali M, et al. DEPDC5-Related Epilepsy. In: GeneReviews®. University of Washington, Seattle. Updated 2024. https://www.ncbi.nlm.nih.gov/books/NBK385626/